Reaction
Plasma Cell Leukaemia reporting signals
As of the last recalculation, Plasma Cell Leukaemia appears in 591 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is CARFILZOMIB (PRR 185.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Carfilzomib | 119 | 185.3 | 186.1 |
| Bortezomib | 205 | 123.1 | 123.4 |
| Daratumumab | 104 | 111.0 | 111.3 |
| Dexamethasone 1.5 Mg | 319 | 82.1 | 82.2 |
| Dexamethasone | 319 | 81.1 | 81.2 |
| Micafungin Sodium | 17 | 72.7 | 72.8 |
| Melphalan | 37 | 61.0 | 61.1 |
| Thalidomide | 55 | 58.1 | 58.2 |
| Lenalidomide | 313 | 54.3 | 54.4 |
| Melphalan Hydrochloride | 36 | 53.8 | 53.9 |
| Ixazomib | 33 | 42.7 | 42.8 |
| Pomalidomide | 102 | 42.0 | 42.1 |
| Etoposide | 62 | 33.1 | 33.1 |
| Bendamustine Hcl | 13 | 30.2 | 30.2 |
| Bendamustine Hydrochloride | 10 | 29.9 | 29.9 |
| Doxorubicin | 66 | 29.2 | 29.3 |
| Cyclophosphamide Injection, Solution | 109 | 26.4 | 26.4 |
| Cyclophosphamide | 109 | 26.4 | 26.4 |
| Cyclophosphamide For Injection | 109 | 26.4 | 26.4 |
| Cisplatin | 51 | 25.1 | 25.1 |
| Tranexamic Acid | 6 | 24.0 | 24.0 |
| Selinexor | 5 | 20.5 | 20.5 |
| Doxorubicin Hydrochloride | 15 | 16.6 | 16.6 |
| Venetoclax | 23 | 13.6 | 13.7 |
| Sevelamer Carbonate | 4 | 12.3 | 12.3 |